Novartis improves ranking in 2016 Access to Medicine Index Submission Details
Author: Kerry Simpson from Bespoke Communications.
More Info link: http://novartis.com
About Novartis
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are available in approximately 180 countries around the world. For more information, please visit http://www.novartis.com.
Novartis improves ranking in 2016 Access to Medicine Index
- Novartis ranks third in 2016 ranking
- Company tops the industry in access-to-medicine management and capacity building
- Novartis integrated access strategy addressing all income segments stands out as best practice
Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis
For Novartis multimedia content, please visit www.novartis.com/news/media-library
For questions about the site or required registration, please contact media.relations@novartis.com
# # #
Novartis Media Relations
Central media line: +41 61 324 2200
E-mail: media.relations@novartis.com
| Eric Althoff
Novartis Global Media Relations +41 61 324 7999 (direct) +41 79 593 4202 (mobile) |
Carrie Scott
Corporate Brand & Reputation +41 61 324 3435 (direct) +41 79 264 4121 (mobile) |
Novartis Investor Relations
Central investor relations line: +41 61 324 7944
E-mail: investor.relations@novartis.com
| Central | North America | ||
| Samir Shah | +41 61 324 7944 | Richard Pulik | +1 212 830 2448 |
| Pierre-Michel Bringer | +41 61 324 1065 | Sloan Pavsner | +1 212 830 2417 |
| Thomas Hungerbuehler | +41 61 324 8425 | ||
| Isabella Zinck | +41 61 324 7188 |
Have a look at the online visibility from 11/17/2016 to today for Novartis improves ranking in 2016 Access to Medicine Index:
- Google Search Results
- Bing Search Results
- Yahoo Search Results
- DuckDuckGo Search Results
- Twitter Mentions
SUBMIT Your Press Release HERE
Hint: Registering on MyPR and ensuring that you are logged in when submitting your press release will seamlessly place your releases under your Author Name. OR – Log in HERE. See our Guidelines.
We are looking for a certain standard and provide these handy hints to help you:
- Answer the 5W’s and 1H: Who, What, When, Where, Why and How.
- Be objective (keep opinions and ‘flowery language’ out of the story).
- Get your facts right.
- Don’t plagiarise.
- Give credit where it is due.
- Cite references.
- Provide URL’s so that your readers can discover more.
- Rather be accurate than first.
- Start with the most important facts first and follow with supporting information.
- Don’t copy and paste your press release from word processing software – use notepad or other.
- See – Google’s Updated Link Schemes Policy and MyPR – for more info.
The press releases that gain the most attention adhere to the above guidelines, are entertaining and are NOT pure sales pitches.
NOTE: Any press releases that do not follow the above guidelines or have no bearing on South Africa, are thinly disguised adverts with no ‘meat’ are deleted.
Track Your Press Release HERE:
Check Online Visibility
Verify where this release is currently indexed:

Fuel2Grow initiative takes over the V&A with a Battle of the Wits.